InvestorsHub Logo
icon url

rgshredder

11/01/21 7:01 AM

#13191 RE: dasgrunt #13190

Great news! It went down 6% in premarket and I was worried, jumped 12% on the news premarket.

Still not sure about the updated labeling last Friday. Per the announcement:

Pregnancy: Since fetal abnormalities have been observed in animals, Cortrophin Gel should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Immunogenicity potential: Prolonged administration of Cortrophin Gel may increase the risk of hypersensitivity reactions. Neutralizing antibodies with chronic administration may lead to loss of endogenous ACTH and Cortrophin Gel activity.

Presume the trade label got updated based on the generic labeling and its subsequent approval under this most recent fda application.

Excited to hear what will be discussed during earnings.
-RG
icon url

LordDarley

11/01/21 7:58 AM

#13194 RE: dasgrunt #13190

Hallelujah! Never been happier about being wrong.